Drug Trial Radar · NCT07637162
Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
300
Planned (sponsor's estimate)
Start
Apr 29, 2026
Primary completion
May 2028
Study completion May 2028
Sponsor
- Lead sponsor
- Axsome Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3, multi-center, 52-week, open-label trial to evaluate the long-term safety and efficacy of AXS-14 in the management of fibromyalgia.
Conditions
- Fibromyalgia
Interventions
AXS-14 (esreboxetine)Drug
AXS-14 tablets taken twice daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Long-term SafetyTime frame: Up to 52 weeks.
Locations
38 sites in 1 country. Site status is shown where the registry gives one.
Clinical Research Site
Little Rock, Arkansas
Clinical Research Site
Anaheim, California
Clinical Research Site
Oceanside, California
Clinical Research Site
Redlands, California
Clinical Research Site
Sacramento, California
Clinical Research Site
Santa Ana, California
Clinical Research Site
Cromwell, Connecticut
Clinical Research Site
Hollywood, Florida
Clinical Research Site
Jacksonville, Florida
Clinical Research Site
Lakeland, Florida
Clinical Research Site
Orlando, Florida
Clinical Research Site
Orlando, Florida
Clinical Research Site
Tampa, Florida
Clinical Research Site
The Villages, Florida
Clinical Research Site
Atlanta, Georgia
Clinical Research Site
Norcross, Georgia
Clinical Research Site
Chicago, Illinois
Clinical Research Site
Overland Park, Kansas
Clinical Research Site
Overland Park, Kansas
Clinical Research Site
Louisville, Kentucky
Clinical Research Site
Prairieville, Louisiana
Clinical Research Site
Boston, Massachusetts
Clinical Research Site
Watertown, Massachusetts
Clinical Research Site
Hazelwood, Missouri
Clinical Research Site
Springfield, Missouri
Clinical Research Site
Town and Country, Missouri
Clinical Research Site
Las Vegas, Nevada
Clinical Research Site
Brooklyn, New York
Clinical Research Site
Williamsville, New York
Clinical Research Site
Tulsa, Oklahoma
Clinical Research Site
Duncansville, Pennsylvania
Clinical Research Site
Charleston, South Carolina
Clinical Research Site
Knoxville, Tennessee
Clinical Research Site
Memphis, Tennessee
Clinical Research Site
Austin, Texas
Clinical Research Site
Austin, Texas
Clinical Research Site
Dallas, Texas
Clinical Research Site
Prosper, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.